ESC 365 - How to manage arrhythmogenic cardiotoxicity and the risk of life-threatening ventricular arrhythmias and sudden cardiac death during cancer therapy?

Open Access

How to manage arrhythmogenic cardiotoxicity and the risk of life-threatening ventricular arrhythmias and sudden cardiac death during cancer therapy?

Session: Protecting the heart during cancer therapy - How to manage the risk of sudden cardiac death?

Topic: Heart Failure

Speaker: Associate Professor D. Farmakis (Athens, GR)

Sponsored by Zoll

Event: ESC Cardio-Oncology 2025

Congress Presentation

Add to my library

About the speaker

Associate Professor Dimitrios T Farmakis

National & Kapodistrian University of Athens, Athens (Greece)

36 presentations

8 followers

3 more presentations in this session

Welcome and introduction

Speaker: Professor I. Goldenberg (Rochester, US)

Recovery of chemotherapy-related acute heart failure - what roles play current HF medication and the Wearable Cardioverter Defibrillator? - interactive case discussions

Speaker: Doctor M. Canale (Lido Di Camaiore, IT)

Discussion and conclusion

Access the full session

Protecting the heart during cancer therapy - How to manage the risk of sudden cardiac death?

Speakers: Associate Professor D. Farmakis, Professor I. Goldenberg, Doctor M. Canale

About the event

ESC Cardio-Oncology 2025

20 June - 21 June 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources